| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances and research priorities in the respiratory management of ALS: Historical perspectives and new technologies
|
Kleinerova, J.
|
|
|
181 |
6 |
p. 525-534
|
artikel
|
| 2 |
An outpatient TIA clinic works! Insights from the creation and the first year of Bordeaux TIA clinic
|
Briau, P.
|
|
|
181 |
6 |
p. 579-586
|
artikel
|
| 3 |
Contents
|
|
|
|
181 |
6 |
p. iii-iv
|
artikel
|
| 4 |
Door-to-puncture time in ischemic stroke with large vessel occlusion in France: Patient and hospital factors
|
Gilbert, F.
|
|
|
181 |
6 |
p. 556-562
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
181 |
6 |
p. i
|
artikel
|
| 6 |
Epileptic seizures recorded with microelectrodes: A persistent multiscale gap between neuronal activity, micro-, and macro-LFP?
|
Calvat, P.
|
|
|
181 |
6 |
p. 503-524
|
artikel
|
| 7 |
French guidelines for the diagnosis and management of pure hereditary spastic paraplegia
|
Mania-Pâris, L.
|
|
|
181 |
6 |
p. 471-482
|
artikel
|
| 8 |
Granulomatous angiitis of the central nervous system (GANS) associated with Hodgkin lymphoma
|
Jeantin, L.
|
|
|
181 |
6 |
p. 587-590
|
artikel
|
| 9 |
Psychoses onset in multiple sclerosis: A systematic review and meta-analysis
|
Ketata, I.
|
|
|
181 |
6 |
p. 483-502
|
artikel
|
| 10 |
Shades of Babinski: Grading the absolute
|
Sohrab, S.A.
|
|
|
181 |
6 |
p. 591-593
|
artikel
|
| 11 |
Superficial white matter hyperintensities are associated with mild tissue alterations in vascular aging
|
Aghetti, A.
|
|
|
181 |
6 |
p. 563-570
|
artikel
|
| 12 |
The diagnostic and therapeutic journey of Tourette syndrome: Thematic analysis of the difficulties experienced by parents of patients
|
Breton, Z.
|
|
|
181 |
6 |
p. 544-555
|
artikel
|
| 13 |
The safety of COVID-19 vaccines in a large French series of patients with neuromuscular conditions and the impacts of vaccination on their daily lives
|
Barnay, M.
|
|
|
181 |
6 |
p. 571-578
|
artikel
|
| 14 |
Trends in the real-world management of patients with active relapsing-remitting multiple sclerosis treated with natalizumab (TYSABRI®) in France: An analysis of the PMSI database over five years (2019–2023)
|
Le Page, E.
|
|
|
181 |
6 |
p. 535-543
|
artikel
|
Tijdschrift beschrijving